Effects of Olfactory Bulbectomy, Melatonin, and/or Pinealectomy on Three Sublines of the Dunning R3327 Rat Prostatic Adenocarcinoma
- 1 July 1987
- journal article
- research article
- Published by Wiley in Journal of Pineal Research
- Vol. 4 (3) , 321-338
- https://doi.org/10.1111/j.1600-079x.1987.tb00870.x
Abstract
Conventional antiandrogen therapy for prostatic cancer generally results in the death of androgen-dependent cells, resulting in shrinkage of the tumor, followed by regrowth of the tumor as androgen-insensitive cells take over. Becuse of reported antigonadotropic and antineoplastic effects of the pineal hormone melatonin (MEL), we hypothesized that this indole might provide an effective therapy for prostate cancer, as it would be effective against both populations of tumor cells. We used three sublines of the Dunning R3327 rat prostatic adenocarcinoma to determine whether MEL could suppress the growth of these tumors and, if so, by what mechanisms this occurs. In one experiment, we compared the growth of a well-differentiated slow-growing Dunning tumor in rats given MEL combined with the potentiating procedure olfactory bulbectomy (BULBX), with that in rats pinealectomized (PINX) or untreated. Tumor growth in BULBX-MEL rats was significantly suppressed over that in the other two groups, as were the weights of the gonads and accessory sex glands. Tumor morphology, DNA concentration, and androgen receptor concentration and distribution were identical in untreated controls and in BULBX-MEL rats, suggesting that the treatment affected all populations of tumor cells equally. With another strain of well-differentiated slow-growing Dunning tumor, we examined the effects of MEL in rats with and without BULBX. Reproductive parameters were not suppressed in BULBX-MEL rats and, while there was a trend toward slower tumor growth in this group, this was not significant. Intact rats given MEL grew larger tumors than did control rats but, again, differences were not significant. In a third experiment, we examined a fast-growing androgen-insensitive anaplastic Dunning tumor. PINX was without effect on this tumor, but BULBX-MEL resulted in a significant suppression of one of the constants in the logistic equation fitted to the growth curves. This indicates that there were some direct antitumor effects of BULBX-MEL on this tumor strain. We conclude that MEL suppresses growth of some Dunning tumor strains.This publication has 21 references indexed in Scilit:
- Applicability of Nuclear Androgen Receptor Quantification to Human Prostatic AdenocarcinomaJournal of Urology, 1986
- Inhibitory Effects of Superior Cervical Ganglionectomy on Dimethylbenz(a)anthracene‐Induced Mammary Tumors in the RatJournal of Pineal Research, 1985
- Evidence for Modulation of Melatonin Secretion in Men With Benign and Malignant Tumors of the Prostate: Relationship With the Pituitary HormonesJournal of Pineal Research, 1985
- The Relationship of Androgen Receptor Levels to Androgen Responsiveness in the Dunning R3327 Rat Prostate Tumor SublinesJournal of Urology, 1984
- Melatonin increases oestrogen receptor binding activity of human breast cancer cellsNature, 1983
- Effect of continuous light on the incidence of 9,10-dimethyl-1,2-benzanthracene induced mammary tumors in female Holtzman ratsCancer Letters, 1982
- Antigonadotrophic and Prolactin-Inhibitory Effects of Melatonin in Anosmic Male RatsNeuroendocrinology, 1979
- Rapid pinealectomy in hamsters and other small rodentsThe Anatomical Record, 1965
- A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acidBiochemical Journal, 1956
- Über eine neue Hormontherapie dee ProstatakrebsesUrologia Internationalis, 1956